The Pathological Basis of Thymoma‐associated Myasthenia Gravis
- 1 June 1993
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 681 (1) , 56-65
- https://doi.org/10.1111/j.1749-6632.1993.tb22869.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor α subunitEuropean Journal of Biochemistry, 1992
- Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravisThe Lancet, 1992
- The Third Euromyasthenia Conference; Meeting Report and Update on Myasthenia ResearchAutoimmunity, 1992
- Neoplastic epithelial cells express α-subunit of muscle nicotinic acetylcholine receptor in thymomas from patients with myasthenia gravisFEBS Letters, 1991
- Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor–reactive T cellsAnnals of Neurology, 1990
- Presentation of antigen, foreign major histocompatibility complex proteins and self by thymus cortical epitheliumNature, 1989
- Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological studyAnnals of Neurology, 1987
- ACETYLCHOLINE RECEPTOR EPITOPES ON EPITHELIAL CELLS OF THYMOMA IN MYASTHENIA GRAVISThe Lancet, 1987
- Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patientsJournal of Neuroimmunology, 1984
- CLINICAL, PATHOLOGICAL, HLA ANTIGEN AND IMMUNOLOGICAL EVIDENCE FOR DISEASE HETEROGENEITY IN MYASTHENIA GRAVISBrain, 1980